Exact Sciences Corporation (EXAS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 63.22 |
| Open | 62.79 |
| Bid | 63.41 x 200 |
| Ask | 63.49 x 200 |
| Day's range | 61.78 - 64.91 |
| 52-week range | 56.05 - 100.77 |
| Volume | |
| Avg. volume | 2,420,254 |
| Market cap | 11.524B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.13 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 90.66 |
ZacksWhy Exact Sciences (EXAS) Dipped More Than Broader Market Today
Exact Sciences (EXAS) concluded the recent trading session at $63.22, signifying a -1% move from its prior day's close.
Simply Wall St.Exact Sciences Corporation's (NASDAQ:EXAS) Profit Outlook
With the business potentially at an important milestone, we thought we'd take a closer look at Exact Sciences...
Business WireExact Sciences Names Aaron Bloomer as New Chief Financial Officer
MADISON, Wis., April 15, 2024--Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024.
© 2024 Yahoo. All rights reserved.